{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T13:06:58Z","timestamp":1769087218458,"version":"3.49.0"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1097\/ico.0b013e31821e65b3","type":"journal-article","created":{"date-parts":[[2011,10,13]],"date-time":"2011-10-13T09:16:22Z","timestamp":1318497382000},"page":"1398-1405","source":"Crossref","is-referenced-by-count":16,"title":["Efficacy of Postoperative Immunosuppression After Keratoplasty in Herpetic Keratitis"],"prefix":"10.1097","volume":"30","author":[{"given":"Anna-Karina B","family":"Maier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevil","family":"\u00d6zl\u00fcgedik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Rottler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian M A","family":"Heussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias K J","family":"Klamann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaudia K","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia M","family":"Joussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibylle","family":"Winterhalter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20-20210204","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00003226-200101000-00001","article-title":"Herpes simplex virus epidemiology and ocular importance.","volume":"20","author":"Liesegang","year":"2001","journal-title":"Cornea"},{"key":"R2-20-20210204","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00417-003-0724-7","article-title":"Synergistic antiherpetic effect of acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease: first results of a randomised pilot study.","volume":"241","author":"Mayer","year":"2003","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R3-20-20210204","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0161-6420(87)33356-1","article-title":"Penetrating keratoplasty for herpes simplex keratitis and keratoconus. Allograft rejection and survival.","volume":"94","author":"Epstein","year":"1987","journal-title":"Ophthalmology"},{"key":"R4-20-20210204","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s003470050217","article-title":"Postoperative complications of penetrating keratoplasty in herpes infected eyes. Differential diagnosis, therapy and prognostic significance [in German].","volume":"94","author":"Kersten","year":"1997","journal-title":"Ophthalmologe"},{"key":"R5-20-20210204","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00003226-199405000-00007","article-title":"A prospective randomized trial of oral acyclovir after penetrating keratoplasty for herpes simplex keratitis.","volume":"13","author":"Barney","year":"1994","journal-title":"Cornea"},{"key":"R6-20-20210204","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/archopht.117.4.445","article-title":"Oral acyclovir after penetrating keratoplasty for herpes simplex keratitis.","volume":"117","author":"Tambasco","year":"1999","journal-title":"Arch Ophthalmol"},{"key":"R7-20-20210204","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/ICO.0b013e318198399a","article-title":"Five-year follow-up on the effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis.","volume":"28","author":"Jansen","year":"2009","journal-title":"Cornea"},{"key":"R8-20-20210204","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.ophtha.2009.03.031","article-title":"Herpes simplex virus keratitis: histopathologic inflammation and corneal allograft rejection.","volume":"116","author":"Shtein","year":"2009","journal-title":"Ophthalmology"},{"key":"R9-20-20210204","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.survophthal.2008.12.004","article-title":"Management of herpes simplex virus stromal keratitis: an evidence-based review.","volume":"54","author":"Knickelbein","year":"2009","journal-title":"Surv Ophthalmol"},{"key":"R10-20-20210204","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0002-9394(89)90494-7","article-title":"The use of cyclosporine in high-risk keratoplasty.","volume":"107","author":"Hill","year":"1989","journal-title":"Am J Ophthalmol"},{"key":"R11-20-20210204","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00168265","article-title":"The use of systemic cyclosporin A in human corneal transplantation: a preliminary report.","volume":"62","author":"Hill","year":"1986","journal-title":"Doc Ophthalmol"},{"key":"R12-20-20210204","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0161-6420(13)31253-6","article-title":"Systemic cyclosporine in high-risk keratoplasty. Short- versus long-term therapy.","volume":"101","author":"Hill","year":"1994","journal-title":"Ophthalmology"},{"issue":"pt 4","key":"R13-20-20210204","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/eye.1995.99","article-title":"Systemic cyclosporine in high-risk keratoplasty: long-term results.","volume":"9","author":"Hill","year":"1995","journal-title":"Eye (Lond)"},{"key":"R14-20-20210204","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s003470050146","article-title":"Preventive systemic cyclosporin A after keratoplasty at increased risk for immune reactions as the only elevated risk factor [in German].","volume":"94","author":"Reinhard","year":"1997","journal-title":"Ophthalmologe"},{"key":"R15-20-20210204","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1136\/bjo.85.12.1464","article-title":"Systemic cyclosporin A in high risk penetrating keratoplasties: a case-control study.","volume":"85","author":"Poon","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"R16-20-20210204","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/00007890-200008270-00018","article-title":"Beneficial effect of HLA-DR matching on the survival of corneal allografts.","volume":"70","author":"Volker-Dieben","year":"2000","journal-title":"Transplantation"},{"key":"R17-20-20210204","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/S0021-5155(01)00339-2","article-title":"Long-term outcome of systemic cyclosporine treatment following penetrating keratoplasty.","volume":"45","author":"Inoue","year":"2001","journal-title":"Jpn J Ophthalmol"},{"key":"R18-20-20210204","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2008-1034699","article-title":"Mycophenolate mofetil after penetrating high risk keratoplasty. A pilot study [in German].","volume":"215","author":"Reinhard","year":"1999","journal-title":"Klin Monatsbl Augenheilkd"},{"key":"R19-20-20210204","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s004170100285","article-title":"Systemic mycophenolate mofetil in comparison with systemic cyclosporin A in high-risk keratoplasty patients: 3 years results of a randomized prospective clinical trial.","volume":"239","author":"Reinhard","year":"2001","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R20-20-20210204","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0166-3542(98)00047-3","article-title":"Mycophenolate mofetil strongly potentiates the anti-herpesvirus activity of acyclovir.","volume":"40","author":"Neyts","year":"1998","journal-title":"Antiviral Res"},{"key":"R21-20-20210204","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1136\/bjo.83.11.1268","article-title":"Mycophenolate mofetil versus cyclosporin A in high risk keratoplasty patients: a prospectively randomised clinical trial.","volume":"83","author":"Reis","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"R22-20-20210204","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1432-2277.2005.00126.x","article-title":"Systemic mycophenolate mofetil avoids immune reactions in penetrating high-risk keratoplasty: preliminary results of an ongoing prospectively randomized multicentre study.","volume":"18","author":"Reinhard","year":"2005","journal-title":"Transpl Int"},{"key":"R23-20-20210204","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1016\/j.ophtha.2004.01.030","article-title":"Penetrating limbo-keratoplasty for granular and lattice corneal dystrophy: survival of donor limbal stem cells and intermediate-term clinical results.","volume":"111","author":"Spelsberg","year":"2004","journal-title":"Ophthalmology"},{"key":"R24-20-20210204","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ajo.2006.01.090","article-title":"Autologous translocation of the choroid and retinal pigment epithelium in age-related macular degeneration.","volume":"142","author":"Joussen","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R25-20-20210204","first-page":"36","article-title":"The relative importance of risk factors used to define high-risk keratoplasty.","volume":"5","author":"Hill","year":"1996","journal-title":"Ger J Ophthalmol"},{"key":"R26-20-20210204","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/bjo.86.6.646","article-title":"The outcome of corneal grafting in patients with stromal keratitis of herpetic and non-herpetic origin.","volume":"86","author":"Halberstadt","year":"2002","journal-title":"Br J Ophthalmol"},{"key":"R27-20-20210204","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/ICO.0b013e3180e79b77","article-title":"Effect of prophylactic oral acyclovir after penetrating keratoplasty for herpes simplex keratitis.","volume":"26","author":"Garcia","year":"2007","journal-title":"Cornea"},{"key":"R28-20-20210204","first-page":"183","article-title":"Highly active antiviral and immunosuppressive combination therapy with acyclovir and mycophenolate mofetil following keratoplasty in patients with herpetic eye disease [in German].","volume":"218","author":"Reisr","year":"2001","journal-title":"Klin Monatsbl Augenheilkd"},{"issue":"pt 2","key":"R29-20-20210204","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/eye.1995.48","article-title":"Immunosuppression in corneal transplantation.","volume":"9","author":"Hill","year":"1995","journal-title":"Eye (Lond)"},{"key":"R30-20-20210204","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/00003226-199409000-00002","article-title":"Corticosteroids in corneal graft rejection: double versus single pulse therapy.","volume":"13","author":"Hill","year":"1994","journal-title":"Cornea"},{"key":"R31-20-20210204","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1001\/archopht.1993.01090040114043","article-title":"Herpetic keratitis: persistence of viral particles despite topical and systemic antiviral therapy. Report of two cases and review of the literature.","volume":"111","author":"Brik","year":"1993","journal-title":"Arch Ophthalmol"},{"key":"R32-20-20210204","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.4049\/jimmunol.161.8.4289","article-title":"Virus-induced immunoinflammatory lesions in the absence of viral antigen recognition.","volume":"161","author":"Gangappa","year":"1998","journal-title":"J Immunol"},{"key":"R33-20-20210204","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.4049\/jimmunol.160.8.3965","article-title":"Immunopathology of herpetic stromal keratitis: discordance in CD4+ T cell function between euthymic host and reconstituted SCID recipients.","volume":"160","author":"Thomas","year":"1998","journal-title":"J Immunol"},{"key":"R34-20-20210204","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archopht.1994.01090170045020","article-title":"Antiviral therapy after penetrating keratoplasty for herpes simplex keratitis.","volume":"112","author":"Moyes","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"R35-20-20210204","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1076\/ocii.7.1.51.8113","article-title":"Efficacy of low-dose and long-term oral acyclovir therapy after penetrating keratoplasty for herpes simplex keratitis.","volume":"7","author":"Akova","year":"1999","journal-title":"Ocul Immunol Inflamm"},{"key":"R36-20-20210204","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/ICO.0b013e31819c4e55","article-title":"Herpes simplex virus keratitis: histopathologic neovascularization and corneal allograft failure.","volume":"28","author":"Garcia","year":"2009","journal-title":"Cornea"},{"key":"R37-20-20210204","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/08820530802111085","article-title":"Ocular HSV-1 latency, reactivation and recurrent disease.","volume":"23","author":"Toma","year":"2008","journal-title":"Semin Ophthalmol"},{"key":"R38-20-20210204","doi-asserted-by":"crossref","first-page":"11462","DOI":"10.1073\/pnas.0503230102","article-title":"Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea.","volume":"102","author":"Polcicova","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R39-20-20210204","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.4049\/jimmunol.167.5.2902","article-title":"Bystander activation involving T lymphocytes in herpetic stromal keratitis.","volume":"167","author":"Deshpande","year":"2001","journal-title":"J Immunol"},{"key":"R40-20-20210204","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/ICO.0b013e318160602d","article-title":"Effect of topical cyclosporin A on herpetic stromal keratitis in a mouse model.","volume":"27","author":"Yoon","year":"2008","journal-title":"Cornea"},{"key":"R41-20-20210204","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0161-6420(89)32668-6","article-title":"The changing management and improved prognosis for corneal grafting in herpes simplex keratitis.","volume":"96","author":"Ficker","year":"1989","journal-title":"Ophthalmology"},{"key":"R42-20-20210204","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00154385","article-title":"Systemic acyclovir and penetrating keratoplasty for herpes simplex keratitis.","volume":"80","author":"Foster","year":"1992","journal-title":"Doc Ophthalmol"},{"key":"R43-20-20210204","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00347-006-1469-6","article-title":"Typing for HLA matching. Advantages for keratoplasty [in German].","volume":"104","author":"Ignatius","year":"2007","journal-title":"Ophthalmologe"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e31821e65b3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,10]],"date-time":"2023-06-10T12:23:39Z","timestamp":1686399819000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201112000-00020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":43,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e31821e65b3","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}